Nederlandse Vereniging voor Klinische Chemie en Laboratoriumgeneeskunde
Find NVKC on TwitterFind NVKC on FacebookFind NVKC on YouTube

Laboratoriumonderzoek speelt bij 70% van de diagnoses een sleutelrol

Wij nemen uw bloed serieus!

PPO Database - projecten

Zoek op naar

 Onderzoekslijnen   Alle projecten   Alle publicaties en voordrachten   Instituten 
Project 53 Tissue engineering of small-caliber blood vessels
Onderzoekslijn Tissue Engineering
Omschrijving Mesenchymal stem cells from bone marrow have been shown to undergo de-differentiation when cultured on fibronectin in the presence of PDGF-BB as well as a number of other mitogens and co-factors. Forward differentiation of these de-differentiated cells into vascular smooth muscle and endothelial cells has been demonstrated. This indicates that a common precursor for vascular smooth muscle and endothelial cells can be generated from bone marrow-derived mesenchymal stem cells.
Human mesenchymal stem cells (CD34-, CD45-; CD29+, CD44+, CD90+, commercially available from Orisis or from single bone marrow donors) will be cultured on fibronectin in the presence of PDGF-BB. During culture, the expression of Oct-4 and Flk1 will be investigated by semi-quantitative PCR and immunofluorescence and used as markers for (increased) pluripotency and VEGF responsiveness, respectively. Differentiation in vascular endothelial cells will be induced by transferring the cells to collagen type IV as substrate followed by addition of VEGF (20 ng/ml). Differentiated derivatives will be investigated for expression of markers characteristic of vascular endothelial cells including von Willebrand Factor, PECAM1 and E and P selectin. Differentiation into vascular smooth muscle cells will be induced by plating the cells on collagen and treatment of confluent cells with PDGF-BB. Differentiation will be characterized by analysis of expression of the smooth muscle cell markers α-SMA and PDGF-β receptor.
Projectleider Prof.dr. I.(Istvan) Vermes
Instituut Medlon BV Enschede
Trefwoorden vascular grafts, stem cells, small-caliber blood vessels,
Status Lopend
Periode 1-2001 - 1-2009
Partners Prof. dr. J. Feijen, University of Twente
Dr. R. Geelkerken, chirurg MST
Medewerkers H. Weekamp, PhD student
P. Engbers-Buijtenhuijs, assistent in opleiding
dr. A.A. Poot, hoofddocent University of Twente
M. Kamphuis, research technician
Financiering 1e Geldstroom - Intern

Dutch Program for tissue engineering (DPTE)